ClinConnect ClinConnect Logo
Search / Trial NCT06737471

Cp eArly REhabilitation

Launched by IRCCS EUGENIO MEDEA · Dec 12, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Cerebral Palsy; Children; Pediatric; Intervention; Rehabilitation; Motor; Cognitive

ClinConnect Summary

The "Cp eArly REhabilitation" trial is studying how effective play-based rehabilitation is for children with cerebral palsy. This type of therapy is being tested in a rehabilitation center that provides both intensive and extensive care. The study aims to find out which format of rehabilitation works better: an intensive approach where children receive therapy three times a day for five days a week over three weeks, or an extensive approach where they receive therapy three times a week for 15 weeks at community centers. By comparing these two methods, researchers hope to learn if the amount of time spent in therapy affects the children's progress.

Children between the ages of 6 months and 5 years who have been diagnosed with cerebral palsy due to various causes may be eligible to participate in this trial. However, children with severe hearing or vision impairments, or those with certain neurological conditions, will not be included. Families participating in the trial can expect their child to engage in fun, play-based activities aimed at improving their skills in a supportive environment. This study is still recruiting participants, so there is an opportunity for eligible families to get involved and help improve rehabilitation methods for children with cerebral palsy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age between 6 months (corrected age in case of prematurity) and 5 years;
  • a diagnosis of cerebral palsy due to perinatal suffering, neurological syndromes, rare diseases with neurological impairment or congenital diseases of unknown nature.
  • Exclusion Criteria:
  • profound deafness and/or severe hypovisus/blindness;
  • a diagnosis of neurodegenerative diseases, acquired brain injury or brain tumor.

About Irccs Eugenio Medea

IRCCS Eugenio Medea is a leading clinical research institute based in Italy, dedicated to advancing pediatric healthcare through innovative research and evidence-based practices. As a recognized center of excellence, it focuses on multidisciplinary approaches to address complex health challenges in children and adolescents, particularly in the fields of neurodevelopmental disorders, mental health, and rehabilitation. The institute collaborates with national and international partners to conduct rigorous clinical trials, aiming to translate scientific discoveries into effective therapeutic interventions. Committed to enhancing patient outcomes, IRCCS Eugenio Medea prioritizes ethical standards and patient safety in all its research endeavors.

Locations

Bosisio Parini, Lecco, Italy

Bosisio Parini, Lecco, Italy

Sesto San Giovanni, Milano, Italy

Carate Brianza, Monza E Brianza, Italy

Vedano Olona, Varese, Italy

Como, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported